In the area of multi-scale modeling of manufacturing processes: (a) Models for understanding the mechanisms of forming and joining of lightweight materials. This new understanding enables the development of advanced processes which remove limitations of current state-of-the-art capabilities that exhibit limited formability of high strength lightweight alloys, and limited reproducibility of joining quality; (b) Innovative multi-scale finite element models for ultrasonic welding of battery tabs (resulting in models adopted by GM for designing and manufacturing batteries for the Chevy Volt), and multi-scale models for ultrasonic welding of short carbon fiber composites (resulting in models adopted by GM for designing and manufacturing assemblies made of carbon fiber composites with metallic parts); (c) Data-driven algorithms of prediction geometrical and microstructural integrity of the incremental formed parts. Machine learning is used for developing fast and robust methods to be integrated into the designing process and replace finite element simulations.
Energy Transportation related topics: data and simulations of various cleaner and ultimately cost-effective options for transit. exploring techno-economic and environmental issues in electric ride-sharing/hailing vehicles to create clean and convenient alternatives to single-occupancy vehicles. investigation of the location and integration of chargers with energy storage and bi-directional services, along with the connection to distributed renewable power generation such as solar arrays as well as the centralized electric grid.
Powertrain related topics: measurements, models and management of batteries, fuel cells, and engines in automotive and stationary applications.
I am interested in using observations, reanalysis, and numerical modeling to investigate the impacts, characteristics and climatology of extreme precipitation events. I use process-based studies for model evaluation and employ simple experiments to develop a mechanistic understanding of weather extremes and their interaction with climate.
Andrea Thomer is an assistant professor of information at the University of Michigan School of Information. She conducts research in the areas of data curation, museum informatics, earth science and biodiversity informatics, information organization, and computer supported cooperative work. She is especially interested in how people use and create data and metadata; the impact of information organization on information use; issues of data provenance, reproducibility, and integration; and long-term data curation and infrastructure sustainability. She is studying a number of these issues through the “Migrating Research Data Collections” project – a recently awarded Laura Bush 21st Century Librarianship Early Career Research Grant from the Institute of Museum and Library Services. Dr. Thomer received her doctorate in Library and Information Science from the School of Information Sciences at the University of Illinois at Urbana‐Champaign in 2017.
Jeffrey Regier received a PhD in statistics from UC Berkeley (2016) and joined the University of Michigan as an assistant professor. His research interests include graphical models, Bayesian inference, high-performance computing, deep learning, astronomy, and genomics.
Samuel K Handelman, Ph.D., is Research Assistant Professor in the department of Internal Medicine, Gastroenterology, of Michigan Medicine at the University of Michigan, Ann Arbor. Prof. Handelman is focused on multi-omics approaches to drive precision/personalized-therapy and to predict population-level differences in the effectiveness of interventions. He tends to favor regression-style and hierarchical-clustering approaches, partially because he has a background in both statistics and in cladistics. His scientific monomania is for compensatory mechanisms and trade-offs in evolution, but he has a principled reason to focus on translational medicine: real understanding of these mechanisms goes all the way into the clinic. Anything less that clinical translation indicates that we don’t understand what drove the genetics of human populations.
My research focus is on the development and application of machine learning tools to large scale financial and unstructured (textual) data to extract, quantify and predict risk profiles and investment grade rating of private and public companies. Example datasets include social media and financial aggregators such as Bloomberg, Pitchbook, and Privco.
Dr. Katz’s research addresses cancer treatment communication, decision-making, and quality of care. His work aims to examine the dynamics of how precision medicine presents itself in the exam room via provider and patient communication and shared decision-making. Dr. Katz leads the Cancer Surveillance and Outcomes Research Team (CanSORT), an interdisciplinary research program centered at the University of Michigan and focused on population and intervention studies of the quality of care and outcomes of cancer detection and treatment in diverse populations. Dr. Katz and CanSORT have been collaborating with Surveillance, Epidemiology, and End Results (SEER) cancer registries since 2002 to study breast cancer treatment decision making at the population level. We obtain patient clinical and demographic information from SEER and combine this with surveys of patients and physicians to create comprehensive data sets that enable us to study testing and treatment trends and the challenges of individualizing treatments for breast cancer patients. In 2015 we added a new dimension to our research by partnering with evaluative testing firms to obtain tumor genomic and germline genetic test results for over 30,000 breast and ovarian cancer patients in the states of California and Georgia. We are also pursuing insurance claims data to assist with our analysis of physician network effects.
The capacity to predict student success depends in part on our ability to understand “educationally purposeful” student behaviors and motivations and the relationship between behaviors and motivations and academic achievement. My research focuses on how to collect student behaviors germane to learning at a higher granularity and analyze the relationships between student performance and behaviors.
Ultimately this research is aimed at designing and constructing an “earlier warning system” wherein student guidance is quasi-automated and informed by motivation, background and behaviors and delivered within weeks of the beginning of classes.
Jeremy Taylor, PhD, is the Pharmacia Research Professor of Biostatistics in the School of Public Health and Professor in the Department of Radiation Oncology in the School of Medicine at the University of Michigan, Ann Arbor. He is the director of the University of Michigan Cancer Center Biostatistics Unit and director of the Cancer/Biostatistics training program. He received his B.A. in Mathematics from Cambridge University and his Ph.D. in Statistics from UC Berkeley. He was on the faculty at UCLA from 1983 to 1998, when he moved to the University of Michigan. He has had visiting positions at the Medical Research Council, Cambridge, England; the University of Adelaide; INSERM, Bordeaux and CSIRO, Sydney, Australia. He is a previously winner of the Mortimer Spiegelman Award from the American Public Health Association and the Michael Fry Award from the Radiation Research Society. He has worked in various areas of Statistics and Biostatistics, including Box-Cox transformations, longitudinal and survival analysis, cure models, missing data, smoothing methods, clinical trial design, surrogate and auxiliary variables. He has been heavily involved in collaborations in the areas of radiation oncology, cancer research and bioinformatics.
I have broad interests and expertise in developing statistical methodology and applying it in biomedical research, particularly in cancer research. I have undertaken research in power transformations, longitudinal modeling, survival analysis particularly cure models, missing data methods, causal inference and in modeling radiation oncology related data. Recent interests, specifically related to cancer, are in statistical methods for genomic data, statistical methods for evaluating cancer biomarkers, surrogate endpoints, phase I trial design, statistical methods for personalized medicine and prognostic and predictive model validation. I strive to develop principled methods that will lead to valid interpretations of the complex data that is collected in biomedical research.